The role of Endocan as a Prognostic Biomarker in community-acquired pneumonia

Abstract

Objective: The aim of this study was to determine the importance of using endocan as a biomarker in deciding the setting of treatment and predicting prognosis in patients with community-acquired pneumonia (CAP).